Blog

Yes, that does say billion in the title of this article. According to Bank of America, the field of antiaging, longevity, and regenerative medicine is set to exceed more than $610 billion by 2025 from its current estimated $110 billion. That’s just in the US. Globally, the market size has reached $17 trillion and is expected to grow to $27 trillion by 2026. “The Longevity Industry will be the Biggest and Most Complex Industry in Human History”, according to the Aging Analytics Agency. These are mind-boggling figures especially since this field is still in its infancy.

Both providers and patients alike are aware that our body changes as we age. Like it or not that’s to be expected. We anticipate that women will go through perimenopause and menopause at some point which of course correlates with changes in steroid hormone levels.

I’m sure that you see patients every single day in your practice that complain of hot flashes, night sweats, foggy thinking, low sex drive, weight gain, fatigue or mood problems such as depression, anxiety or irritability. In fact, 85 percent of women report experiencing symptoms during the menopausal transition.

If you have been following this blog series, you know we have covered progesterone, estrogen, and testosterone deficiency all of which are very common types of imbalance. Lastly, as a provider that manages hormones you will frequently have patients with elevated androgens. These patients may or may not have been previously diagnosed with PCOS. They present with acne, facial hair and menstrual problems suspecting hormone imbalance. These women usually come in before menopause sets in usually between the late teens to mid-thirties and possibly even in the forties.

If you have been following this blog series, you know we have covered progesterone deficiency which correlates with perimenopausal patients and those suffering with PMS. We have also discussed estrogen deficiency which is common in menopausal women. This article covers androgen deficiency in women. Even though androgens include testosterone and DHEA, this article will address testosterone. DHEA deficiency is also common but it is an adrenal hormone and best covered in that context.

This is part 2 of a series of four common types hormone imbalance BHRT providers find in their patients including the causes of the imbalance, typical lab findings, and treatment suggestions.

There are four common categories of patients that new BHRT providers can expect to see repeatedly in their practices. This 4-part series will cover these along with the causes, typical lab findings, and treatment suggestions.